Article thumbnail

Comparative Economic Evaluation of Haemophilus influenzae Type b Vaccination in Belarus and Uzbekistan

By Ulla K. Griffiths, Andrew Clark, Veronika Shimanovich, Irina Glinskaya, Dilorom Tursunova, Lucia Kim, Liudmila Mosina, Rana Hajjeh and Karen Edmond
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3123363
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). Are Haemophilus influenzae infections a significant problem in India? A prospective study and review.
  2. (2009). Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
  3. (2009). Childhood bacterial meningitis in
  4. (2010). CHOosing Interventions that are Cost Effective (WHO-CHOICE) http://wwwwhoint/choice/country/en/. Economic Evaluation of Hib Vaccination PLoS
  5. (2007). Comparative Study of PCR and Bacteriological Method in the Diagnostics of Meningitis.
  6. (1994). Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden.
  7. (2008). Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches.
  8. (1996). Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France.
  9. (2011). Cost-effectiveness thresholds.
  10. (2005). Describing the epidemiology and aetiology of bacterial pneumonia in children: an unresolved problem.
  11. (2007). Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.
  12. (1998). Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.
  13. (2006). Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
  14. (2006). Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis.
  15. (1992). Epidemiology of invasive Haemophilus influenzae type b disease.
  16. (2002). Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria: a prospective, population-based surveillance study.
  17. (2001). Estimating the local burden of Haemophilus influenzae type b (Hib) disease preventable by vaccination. A rapid assessment tool.
  18. (2008). Features of Hib infection epidemic process
  19. Fomenko A (2008) Belarus: Health system review.
  20. (2011). GDP per capita (current US$).
  21. (2010). Global and regional risks of disabling sequelae from bacterial meningitis.
  22. (2010). Global use of Haemophilus influenzae type b conjugate vaccine.
  23. (2010). Global, regional, and national causes of child mortality in 2008: a systematic analysis.
  24. (2002). Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates.
  25. (2004). Health service utilization in the former soviet union: evidence from eight countries.
  26. (2002). Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
  27. (2005). Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data.
  28. (2000). Introduction of Haemophilus influenzae type b vaccine into immunization programmes. Management guidelines, including information for health workers and parents.
  29. (1993). Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91).
  30. (2009). Methods to estimate the global burden of disease due to Haemophilus influenzae type b and Streptococcus pneumoniae in children less than 5 years of age. Lancet Web annex.
  31. (2009). Miners A
  32. (2005). Outcomes of Hib-meningitis incidence study and outlooks for immunoprophylaxis. Epidemiology and Infectious Diseases Magazine 3.
  33. (2008). Population Secretariat
  34. (2010). Product menu for vaccines supplied by Unicef for the GAVI Alliance.
  35. (2002). Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States,
  36. (1997). Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
  37. (2007). Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine.
  38. (2003). The
  39. (2010). The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.
  40. (1996). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in
  41. (2006). Uzbekistan. Multiple Indicator Cluster Survey,
  42. (2008). WHO guide for standardization of economic evaluations of immunization programmes; Immunization, Vaccines and Biologiocals Department,
  43. (2010). WHO Vaccine Preventable Diseases Monitoring System.
  44. (2011). World Development Indicators.